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Abstract
Autologous cancellous-bone grafts are the current gold standard for therapeutic interventions in
which bone-regeneration is desired. Themain limitations of these implants are the need for a
secondary surgical site, creating awound on the patient, the limited availability of harvest-safe bone,
and the lack of structural integrity of the grafts. Synthetic, resorbable, bone-regenerationmaterials
could pose a viable treatment alternative, that could be implemented through 3D-printing.We
present here the development of a polylactic acid-hydroxyapatite (PLA-HAp) composite that can be
processed through a commercial-grade 3D-printer.We have shown that thismaterial could be a viable
option for the development of therapeutic implants for bone regeneration. Biocompatibility in vitro
was demonstrated through cell viability studies using the osteoblasticMG63 cell-line, andwe have also
provided evidence that the presence ofHAp in the polymermatrix enhances cell attachment and
osteogenicity of thematerial.We have also provided guidelines for the optimal PLA-HAp ratio for this
application, as well as further characterisation of themechanical and thermal properties of the
composite. This study encompasses the base for further research on the possibilities and safety of 3D-
printable, polymer-based, resorbable composites for bone regeneration.
1. Introduction
Implants and grafts for surgical reconstruction of the
skull vary widely in presentation and characteristics,
which are in turndependantof the clinical requirements
of each individual patient, and on how the complex
geometries of their cranial bones are affected [1–3].
Some common craniofacial bone defects, such as the
alveolar defects oncleft lip andpalate (CP) and incidents
that warrant orbital floor reconstruction (OFR) pose
unique challenges for the production of bone implants
to meet their specific therapeutic goals, as well as to suit
the irregular geometries and high variability between
individual lesions in each case. In both of these kinds of
reconstructive surgeries, an implant is required to
restore as much mechanical function as possible to the
affected bone structures, and restoration of some of the
biological functions of the affected site is desirable if at
all possible (e.g. self-healing, or tooth eruption).
Given the geometric intricacies that tend to arise
frombone defects and lesions, numerous forms of 3D-
printing have been gaining interest in research for
patient-specific bone-repair devices [4–14]. Defects
and fractures are further complicated in skull bones
due to their overall thinness, size, closeness to neuro-
vascular bundles, and inter-patient anatomic varia-
bility. These challenges are currently met with
standardised plates, screws, fixtures and other such
devises which, though effective, have limitations that
must be overcome with careful pre-operatory plan-
ning, and in-theatre adjustment of the devices. This
results in a natural niche for improvement where
patient-specific devices could help improve treatment
outcomes or limit complications [15–17]. Evidence
for the overall outcome of surgical maxillofacial inter-
ventions is more readily available in disease-specific
studies, and it has been pointed out that broad areas like
facial trauma surgery lack sufficiently evidenced studies
in regards of outcomes [17]. Having this in mind, we
selected the fore-mentioned applications of CP max-
illary reconstruction, and OFR as their expected out-
comes, possible complications, and relationship with
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implant customisation has been well studied, and they
could clearly benefit from the implementation of 3D-
printing for bone regeneration.
In CP, most treatment schemes will fit reconstruc-
tive surgery of the maxillae within the first 15 years of
age of the patient. As such, patients are likely to receive
treatment during very active bone growth periods,
where maxillary implants have been shown to disrupt
normal facial development [18–22], whereas no
reconstructive treatment often leads to dental, aes-
thetic, and psychological issues [20, 23–25]. Currently,
the gold standard implant for this surgery is a hip can-
cellous-bone autograft, which promotes osteogenesis
at the implant site [26]. This comes at the expense of
the graft-harvest site, where secondary morbidities,
including chronic pain, infections and fractures, are
common [21, 23, 27–29]. These grafts lack structural
integrity and in the long term tend to require a second-
ary grafting procedure to treat this and other possible
complications [22, 29]. On the other hand, autologous
grafting bypasses any biocompatibility concerns that
are central to the development of materials for long-
term implants [30, 31].
OFR techniques regularly use autologous and
allogeneic cortical bone implants, but titanium,
polypropylene, polyethylene, polytetrafluoroethylene,
polyglycolic acid, and PLA are also popular materials
for this application [2, 3, 32–34]. In contrast with
alveolar repair on CP, the internal floor of the orbit is
aims to support the weight of the structures therein—
about 43 g [32]. Especially if the lesion compromises
the entirety of the orbital floor, meshes and implants
used on this context must be able to provide mechan-
ical support for their own mass and the weight of the
intra-orbital structures, making cancellous grafts
inappropriate for the application and thus limiting
options for bone regeneration. Implants for OFR are
meant to be permanent, and they have been suggested
as contributors in complications immediately follow-
ing OFR, namely in early-onset retrobulbar haema-
toma [35].
There has been some growing concern about the
implementation of 3D printing on implant produc-
tion, since official regulations addressing this manu-
facturing technique are not currently in place [36].
Biocompatibility and biodegradability of polymers
such as polylactides—such as the polylactic acid (PLA)
used in the present work—have been extensively ver-
ified and documented in vitro and in vivo [30, 31,
37–39]. However, there currently is limited published
data on these properties for polylactides processed
through fused filament fabrication (FFF) 3D printing.
Other molecular-level enhancement techniques such
as self-reinforcing have not been noted to affect in vivo
degradability and tissue response [40, 41]; so it can be
hypothesised that appropriate sterilization of machin-
ery and implants is enough to address these concerns.
FFF, on the other hand, is not a bulk manufacturing
technique, in the sense that the whole mass of the
part is processed at once—as in mould casting, for
instance. One of the objectives of the present research
is to identify the effects the layer-by-layer production
process of FFF has on PLA’s characteristics as a bioma-
terial. The FFF workflow we developed has the advan-
tage of not requiring the use of any solvents—as PLA-
HA composites regularly do [42–45].
Taking PLA as a structural biocompatible (and
mostly bioinert) base for a composite, hydroxyapatite
(HAp) was selected as a potential bone-regenerating
functionalisation agent. HAp offers micro-scale parti-
culates and thermal-stability at the processing tem-
peratures of PLA 3D-printing filament extrusion and
FFF, a consistent affinity for organic molecules, and
documented osteoconductive properties [6, 46–50].
The current study will present results from the devel-
opment for amethod for thorough integration of HAp
particles into a PLA matrix in the form of a 3D-prin-
table filament. At the time of writing, not many pub-
lications have attempted a similar production method
for PLA-HAp composites [7, 44, 45, 51]. Some other
publications have also dealt with compositing various
ceramics into polymer matrixes for a variety of addi-
tive manufacturing methods within bone-regenera-
tion [6, 9, 10, 14, 52–55]. Of these, only three
publications can be found that have studied with simi-
lar composites specifically for FFF with some success
[6, 9, 14]. We developed and characterised a bior-
esorbable 3D-printing filament made of a PLA-HAp
composite for the production of bone-regeneration
implants, as substitutes for current applications where
non-load-bearing autografts are the gold standard.
2.Materials andmethods
2.1. Compositefilament production
The PLA-HAp composite filament used for this study
was produced using a Filabot Original Filament
Extruder (Filabot, USA) retrofitted with an external
extrusion rate control; an external fan was used for
cooling of output filament. This extruder works by
taking plastic pellets fed into its top hopper and driving
them with a screw into a melting chamber and out
from a 3mm nozzle. The final output was a polymer
filament 2.85 to 3 mm in thickness, suitable as feed
filament for the BFB-3000 3D printer (3D Systems,
USA) implemented in this study.
The composite was produced through weight-to-
weight mixtures of High Performance Polylactic Acid
3D Printing Filament (Verbatim, UK) with HAp Cap-
tal S hydroxyapatite powder (Plasma Biotal, UK).
These rawmaterials were selected as proof-of-concept
proxies for medical-grade materials. The 3D-printing
specialised PLA differs from medical-grade lactides in
that it is lower molecular weight, which translates
to weaker and more flexible mechanical properties:
these are beneficial for extrusion and printing.
This HAp powder was sintered with a particle size of
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D50=3.59 μm, selected to be on the lower end of
micro-scale HAp after pilot tests with nano-scale pow-
ders (data not shown) proved difficult to integrate into
the polymer. For production of composite pellets, the
raw PLA filament was cut into ∼5 mm segments,
manually mixed with the HAp powder in a polytetra-
fluoroethylene (PTFE) container, and then molten at
185 °C in a drying oven for 3 h. Afterwards, the oven
was turned off, and the mixture was then left to cool
for at least 6 h to ambient temperature. This resulted
in a 10 cm in diameter, ∼5 mm thick composite disc
(figure 1(a)) that was then cut down again to ∼5 mm
roughly cubic pellets to be fed to the filament extruder
(figure 1(b)). This pellet size was selected in accor-
dance to manufacturer’s recommendations given the
spacing of the extruder’s threading.
The HAp to PLA proportions trialled in these
experiments were 5%, 10%, and 20% by weight. The
extrusion temperature for all of these was set to
190 °C, with the produced filament (∼3 mm in dia-
meter) pulled out and spooled by hand. The extrusion
rate and output cooling were manually adjusted dur-
ing production in order to maintain consistent output
diameters and curvatures throughout the filament.
Monitoring of these macroscopic characteristics was
done by direct inspection as the filament was being
extruded. Samples 3D-printed from non-composited,
non-treated PLA were used as control throughout the
study. For simplicity, these are referred as ‘pure PLA’
from here on. Figure 1 shows a variety of 3D-printed
samples made with the 10%HAp version of the com-
posite, including a complex meshed cube as a test for
printability (figures 1(d)–(h)).
2.2.MG63 biocompatibility testing
2.2.1. Cell preparation
MG63 osteosarcoma-like cells were cultured in
α-MEM expansion medium (EM) with foetal bovine
serum (FBS, 10% volume by volume), 100 IU ml−1
of penicillin, 2.5 μg ml−1 of streptomycin, and
2.92 mgml−1 of L-glutamine. The cells were incu-
bated in 5% CO2 at 37 °C in T-72 flasks until >80%
confluence was achieved. At that point they were
passaged into a new flask, or used for seeding into
samples. Cells seeded on samples were cultured in EM
for the first 24 h, then switched to a supplemented
medium (SM), consisting of EM with added
50 μg ml−1 of ascorbic acid and 10 mM β-glyceropho-
sphate, in order to promote extracellular matrix
mineralization.
2.2.2. Cell viability bymetabolic activity assay
In vitro testing of the materials was carried out on 3D
printed discs of 10 mm in diameter (figure 1(c)); all
discs used in these experiments were 3D-printed using
a BFB-3000 3D-printer (3D Systems). Discs were
seeded with 5000 cells on one of their faces. Seeding
was done with the cells suspended on 50 μl of EM,
followed by an incubation period of 45 min, and then
addition of 2 ml of EM to each sample well. Each
iteration consisted of four discs of the material version
to be tested. Additionally, control experiments were
setup with pure PLA discs as control, and annealed
PLA discs were included to investigate if polymer
crystallinity had any effect on in vitro cell behaviour.
PLA discs were annealed in a pre-heated oven at
120 °C for 4 h. Cooling down to environmental
temperaturewas then allowed inside the closed oven.
Samples were then placed in a 12-well cell-culture
plate, with one sample per well, laid flat with the face
to be seeded facing up. After seeding, they were then
covered by 2 ml of OM, completely submerging each
disc; plates were left to incubate at 37 °C. Metabolic
activity was measured over 21 days using resazurin
reduction assays (RRA), and then comparing absor-
bance readings against a standard curve to determine
an approximate cell count. Sampling time periods
were set at days 1, 4, 7, 14 and 21 after seeding. This
seeding strategy was also used on empty tissue culture
plastic (TCP)wells as reference.
For RRA, the samples were stained with 2 ml EM
with 27.9 μg ml−1 of resazurin salt (Sigma-Aldrich),
and were incubated at 37 °C for 4 h. Excitation-emis-
sion measurements were then performed in triplicate
Figure 1. (a)Pre extrusion PLA-HAp solidifiedmixture as a 5 mm thick disc; (b) 3D-printing filamentmade of PLA-10%HAp
composite; (c) 3D-printed cell culture disc; (d) front view of 3D-model of a 10 mm3 complexmeshwith connected porosity; (e) side
view; (f) top view; (g) isometric view; (h) 3D-printed sample of themeshmodelmadewith PLA-10%Hap; i) tensile bar sample
specimen.
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on a Tecan Infinite 200 Pro plate reader at
λex=540 nm and λem=590 nm. Measurements
were compared to a RRA-cell number standard curve
to estimate cell counts for each sample. This experi-
ment was run twice with triplicate samples (such that
n=6). Once the final viability time period was tested,
the samples were fixed with a 10% volume by volume
formaldehyde solution.
2.2.3. Cell attachment
On day 1 of the viability study, the sample discs were
moved to new well plates before RRA staining in order
to evaluate only cells attached to the sample. RRA
measurements were taken from the original plates,
and were compared to a standard curve to estimate the
number of cells left on each well after removal of the
sample discs, giving an estimate of seeding efficiency.
2.2.4. Calcium and collagen deposition
In order to evaluate in vitro osteogenic activity of the
MG-63 cell line, measurement of extracellular matrix
deposition and mineralisation of said extracellular
matrix were measured. To this end, Alizarin Red S
assays (ARS, Sigma-Aldrich) were used to evaluate the
calcium deposition achieved by the MG63 cells at
culture day 21. Samples were fixed in a 37% formalde-
hyde solution, and then were submerged in a 1%
weight-by-volume ARS solution for 30 min, and then
washed with de-ionized water (DIW) after periods of
5 min with orbital shaking at 50 rpm. Samples were
de-stained in 2 ml of 5% perchloric acid (chloric(VII)
acid) for 15 min with orbital shaking, and absorbance
was measured in triplicate in the plate reader at
405 nm and compared to an ARS-concentration
standard curve. Background signal and non-extracel-
lular matrix calcium were controlled for by including
non-seeded (blank) discs. These non-seeded discs
matched the material (and HAp concentration) of the
seeded samples and were run along with them.
Subtraction of the fluorescence reading of these blanks
was used to remove the effect of scaffold staining.
Similarly, collagen deposition was measured using
Sirius Red staining (SRS). The SRS solution was pro-
duced as a 1% weight-by-volume solution of Direct
Red 80 (Sigma-Aldrich, UK) in 1.3% picric acid (2, 4,
6-trinitrophenol). The samples were washed in DIW
after ARS, and then submerged for one hour in SRS
solution under orbital shaking at 100 rpm. The stain-
ing solution was then washed out with repeated DIW
after 5 min intervals of orbital shaking at 50 rpm. Each
sample was then de-stained by adding 2 ml of 0.2 M
NaOH:methanol and leaving in orbital shaking at
100 rpm for 20 min. Absorbance of the de-stain solu-
tion was thenmeasured in triplicate in the plate reader
at 405 nm, and compared to an SRS-concentration
standard curve. Blank discs were used to control for
background signal. These non-seeded discs matched
the material of the seeded samples and were run along
with them. Subtraction of the fluorescence reading of
these blanks was used to remove the effect of scaffold
staining.
2.3.Mechanical testing
Thepull-to-break tensile testing protocol was followed
as described in ASTM D638-03, in order to determine
ultimate tensile strength (UTS) and elastic modulus
(E). Tensile bar specimens weremanufactured accord-
ing to this same standard (figure 1(i)). They were
subject to an elongation of 1 mmmin−1 (recom-
mended for smaller specimens) until fracturing
occurred. Tensile testing was conducted on an LRX
universal Testing Machine (Lloyd Instruments). As
per the standard, five samples were tested (n=5).
2.4. Thermal andmolecular weight analysis
Thermal properties of the materials at different
stages of the production process were analyzed using
a Diamond TG/DTA scanning calorimeter (Perkin
Elmer). For testing, samples of around 10 mg of the
material were loaded into 40 μl aluminium sample
pans. Testing temperature was held at 40 °C for 1 min
in order to stabilize the starting conditions. Thermal
scanning was then conducted at 10 °Cminute−1 up to
500 °C, with a sampling rate of about 4.3 measure-
ments per second. Polymer crystallinity (Cr) was
estimated through enthalpymeasurements [39, 56–58],
such that:
( )
% %
%

Cr
H H
H
% 1
f c
100
WhereΔHf is the fusion enthalpy,ΔHC is the crystal-
lisation enthalpy, and ΔH100 is a known value for
fusion enthalpy for a fully crystalline lattice of the
material in question. For PLA, this value is reported to
be 91.3 J g−1 [59, 60].
2.5. CompositeHAp concentration and distribution
As the TG/DTA process also registers gravimetric data
alongwith the rest of itsmeasurements, it is possible to
approximate the amount of HAp contained in a
composite sample after the polymer decomposes from
300 °C to 400 °C. HAp is unaffected at these tempera-
tures, and thus should remain in the sample pans at
the end of the run, and be detectable as a plateau in the
weight measurements [61]. These data were obtained
in triplicate for each step of the composite production
process: pure PLA filament, pre-extrusion composite
mixture, 3D-printing composite filament, and 3D-
printed composite.
In order to examine the homogeneity of HAp dis-
tribution within the polymer matrix, we utilised a FEI
Inspect F50 Scanning Electron Microscope (SEM)
with Electron Dispersive Spectroscopy (EDS)module.
Scanning Electron Microscopy with Electron Dis-
persive Spectroscopy (SEM-EDS) was performed on
cross-sections of 3D-printed samples from each pro-
duction step to observe their elemental composition
and distribution. Additionally, micro Computed
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Tomography (μCT) using a Skyscan 1172 High Reso-
lution Micro-CT (Bruker microCT). Imaging was
done at a voltage of 50 kV, 180° rotation, and exposure
of 1210 ms. These imaging data were used to produce
3D reconstructions of the volumetric distribution of
ceramic particles within a 3D-printed specimen.
In order to assess the effects of processing in the
molecular structure of the polymer matrix, we ana-
lyzed samples throughout the production process
using Gel Permeation Chromatography (GPC) in a
1090 HPLC equipped with UV–vis and Differential
Refractive Index Detectors (Hewlet-Packard, UK). For
each stage of the production process, triplicate sam-
ples of 10 mg ofmaterial were dissolved in chloroform
to 0.10 mgml−1, and were then subjected to GPC,
with results reported as calibrated against a poly-
styrene standard.
2.6. Statistical analysis
Data for these experimentswas processed and analysed
using Graphpad Prism 7.03. Data gathered through
several time points (such as 23-day cell culture assays)
was compared through Two-Way ANOVAwith Sidak
hypothesis testing for multiple comparisons. Data
gathered on a single time point (such as collagen and
calcium deposition)was compared through One-Way
ANOVA with Tukey hypothesis testing for multiple
comparisons. Significance level was defaulted to
p>0.05; this value is also clarified for each
experiment.
3. Results
3.1.Material biocompatibility in vitro
The MG63 cell line grew well on all tested materials
under the conditions of this study (figure 2). In terms
of cell attachment, the 10% HAp and 20% HAp
composites supported higher initial cell numbers with
respect to the control PLA (p<0.05). The 10% HAp
composite was significantly more favourable for
attachment than the 20%HAp version (p<0.05).
Cell viability (metabolic activity) increased over
time in all samples (figure 3) and there were only sig-
nificant differences (p<0.05) at day 14, when the 5%
HAp and 20% HAp PLA composites supported lower
cell numbers than the other materials. These differ-
ences were not observable by day 21, but all samples
reached significantly higher cell counts (p<0.05)
than the reference tissue culture plastic (TCP).
3.2. The ability of thematerials to supportmatrix
deposition andmineralisation
MG63 calcium deposition over 23 days on the sample
discs was slightly but significantly higher in the 5%
HAp and 20% HAp composites with respect to pure
PLA controls (p<0.05) (figure 4). However, only the
20% HAp composite supported higher collagen
deposition than the TCP reference group (p<0.05).
3.3. Composite characterisation
3.3.1. Composite selection
The 10% HAp composite was found to be pose less
problems during extrusion and 3D-printing—this was
the main reason for the final decision in favour of this
formulation. Moreover, the cell culture tests indicated
it supported cells as well as the other composite
versions by the end of the trial period, and also
performed marginally better for cell-attachment.
Further characterisation was thus performed on speci-
mens of the 10% HAp composite only. Pure PLA
samples were tested as a base reference, and annealed
Figure 2.MG63 cell-line attachment on 3D-printed discs of different PLA composites. Cell attachmentmean±S.Dwas calculated as
the proportion of cells asmeasured by theirmetabolic activity remaining on the samples versus those remaining in the incubation
wells. *=significantly different (p<0.05) frompure-PLA control discs; n=6 from triplicate samples on two biological repeats.
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PLA was tested to assess any effects of changes in
crystallinity.
3.3.2.Mechanical testing
Mechanically (figure 5(a)), the composite was found to
have lower UTS (28.65 MPa) than non-annealed PLA
(48.46 MPa) and similar to annealed PLA tensile bars
(27.74 MPa). This meant that both annealed and
composite samples were about 40% weaker than pure
PLA controls. There were no significant differences
between the 10% HAp composite and the annealed
material (p<0.05).
Elastic modulus was very similar between pure
PLA (202.4 kPa) and the annealed tensile bars
(178.9 MPa), the difference being non-significant
(p<0.05) (figure 5(b)). However, elastic modulus of
the 10%HAp composite (126.5 MPa)was significantly
lower than that of pure PLA (p<0.05).
3.3.3. Thermal analysis andHAp distribution
Polymer crystallinity values were calculated from diff-
erential calorimetry through equation 1 (figure 6(a)).
Only annealing showed a significant effect on the raw
material’s crystallinity value, increasing it by 66% with
respect of the raw PLA filament (p<0.05). Neither
3D-printing nor melting for composite production,
nor extrusion into composite filament had a significant
effect on the material’s original crystalline content
(p<0.05). Moreover, 3D-printed parts from both raw
and composite filaments showed no significant differ-
ence compared to each other (p<0.05). In terms of
molecular weight, the material remained consistent
through processing before 3D-printing. The combina-
tion of further heating and the pressure from extrusion
during printing likely provide enough energy to cause
the significant lowering on molecular weight observed
(figure 6(c)). In turn, this could explain the lowering
of elasticity and tensile strength mentioned above
(figure 5).
The HAp content of the analyzed samples at the
three consecutive stages of the composite filament
production process was measured through TGA
(figure 6(b)). This reflects the ceramic left over after
polymer matrix decomposition during calorimetry.
Figure 3.MG63 cell-line viability results observed over 21 on 3D-printed discs of the PLA variants studied. Stars denote significant
differences (p=0.05) from the pure PLA control group. TCPmeasurements are included as a reference for baseline cell-line viability.
*=significantly different (p=0.05) frompure-PLA control discs; n=6 from triplicate samples on two biological repeats.
Figure 4. (a)MG63 cell-line calcium and (b) collagen deposition over 23 days on the PLA variants studied. Presence of both substances
was evaluated throughARS and SRS essays, respectively. *=significantly different (p=0.05) frompure-PLA control discs; n=6
from triplicate samples on two biological repeats.
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There was no statistical difference between the pre-
extrusion composite, the extruded filament, or the
3D-printed parts made of the 10% HAp composite
(p<0.05). An average of 7%-by weight-HAp content
was found throughout the whole process, being lower
than the 10%-by-weight used when mixing the raw
components, with wider dispersion of the data after
the initial melting into the composite disc. SEM-EDS
images of cross-sections of filament and 3D-printed
samples demonstrated uniform distribution of Ca and
P atoms (figures 7(c), (d), (h), (i)) on the analysed area,
with the O atoms’ distribution (figure 7(c)) shown as a
reference for the PLA matrix, which dominates as
expected. Characteristic peaks for Ca and P were
found in all samples except the pure PLA one. The
most defined peaks for Ca and P appeared in the 3DP
composite filament, and the 3D-printed composite
specimens (figures 7(b), (g)). EDS data is presented
qualitatively, since the facture surface analysed could
not be completely flattened and smoothed: both fac-
tors were considered to affect elemental quantifica-
tion. Additionally, the scanned surfaces (especially
those on the 3D-printed sample) showed numerous
zones of charge artefacts, thus the analysed area’s irre-
gular geometry was selected so as to cover the largest
possible section of artefact-free image.
The behaviour of the materials under differential
calorimetry was as expected for PLA, (figure 9). The
changes in crystallinity mentioned above are apparent
in these curves, with the most notable variation being
the obliteration of the crystallization peak on the pre-
extrusion composite disc—along with its re-appear-
ance after extrusion into a 3D-printing filament. Addi-
tionally, melting for composite production appeared
to induce an increase in heat capacity on the polymer’s
structure, inferred from the offset of its curves along
Figure 5. (a)Tensile strength and (b) elasticmodulusmeasurements for pure PLA (as control group), annealed PLA, and the 10%HAp
composite used in this study. (c)Representative stress-strain yield curves for one sample of each of thematerials. Pull-to-break testing
was conducted on 3D-printed tensile bars (n=5), bothwith specifications as perASTMD638-03. *=significantly different
(p<0.05) frompure-PLA samples; n=5.
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the heat-flow axis. Extrusion, on the other hand, yields
a small difference in this respect, while 3D-printing
pushes a further increase. Notably, 3D-printing of the
raw filament did not produce any large effect on heat
capacity—the curve is not shown as it closely overlaps
with that of the raw material. The average melting
temperature for the 3D-printed composite (∼174 °C)
was significantly lower than for the other materi-
als (p<0.05).
Reconstruction through μCT of a 3D-printed disc
like those mentioned for cell culture (figure 1(c))
revealed an uniform distribution of microscopic
radiopaque particles on the outermost surfaces of the
sample (figure 8(a)). These can be seen in the images as
uncountable lighter spots interposed with darker,
more radiolucent polymer matrix. Adjusting the
reconstruction parameters to exclude low-opacity
sections of the images, it was possible to produce an
3D mapping of the distribution of what appears to be
HAp particles. This volumetric dispersion was con-
sistent with SEM-EDS observations.
4.Discussion
The results presented here address gaps in our knowl-
edge regarding the biological properties of 3D-printed
PLA, as well as its implementation as a composite for
FFF– which has not been thoroughly studied. PLA is
currently deemed safe for clinical use, a claim firmly
supported in the literature [30, 31, 38, 39, 62–64]. The
aim of this study and the on-going research behind it is
to develop viable solutions for bone-regeneration
applications, implemented through additivemanufac-
turing. As a newer fabrication process, FFF in the
context of therapeutics has only recently received
Figure 6. (a)Percent crystalline content after different processing stages for PLA; from left to right, bars correspond to: the 3D-
printing filament used as rawmaterial for this study; rawmaterial after being 3D-printed; 3D-printedmaterial after annealing; 10%
HAp composite disc before feeding to the Filabot extruder; the output 10%HAp composite filament from the extruder; and the 10%
HAp composite filament after being 3D-printed. (b)HAp content in the composite variants tested; bars correspond to the last three
materials offigure 6(a). (c)Number-averagemolecular weightmeasurements corresponding to the samematerials as in (a).
*=significantly different (p=0.05) frompure-PLA samples; n=3.
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more attention in academic publications. Although
there is little reason to believe 3D-printing could affect
the safety of PLA and HAp, custom implants with
biological inductors will foreseeably be classified as
Class III medical device, and will therefore be required
to adhere to good manufacturing practices. As such,
strong evidence must be produced to support the
biological safety of 3D-printing in the production of
polymer-based composite implants [65].
Here we have shown that in vitro biocompatibility
is clearly unaffected in 3D-printed materials made
with commercial-grade PLA. Thoughmetabolic activ-
ity may not remain constant per-cell during these
kinds of experiments, RRA is generally accepted as an
indirect measure of cell growth, as increase in meta-
bolic activity alone is unlikely to yield readings increas-
ing several orders of magnitude [66]. We have also
provided evidence that these materials perform simi-
larly to tissue culture plastic in terms of supporting cell
metabolic activity which is an indicator of viability.
With respect of the 10%HAp formulation we selected,
at least onemore group has reached a similar formula-
tion for PLA-HAp composite for 3D-printing [7], but
yet others have been successful with formulations of
up to 50% HAp [6, 9]. Differences in raw materials
between results in this and the cited studies are likely
the culprits behind the range of viable formulations
for compositing PLA-HAp for FFF. It has been poin-
ted out for similar polymer-ceramic composites that
the main benefit of ceramic particulates comes from
increased surface roughness enhancing cell-attach-
ment [14], which might be the mechanism behind
increased cell-attachment measurements in compo-
sites when compared to pure PLA and the lowest con-
centration (5%HAp) we evaluated. Given that surface
roughness influences cell attachment, but cell proxi-
mity is necessary for long term survivability, we hypo-
thesize that the significant differences favouring
Figure 7. SEM-EDS images of 3D-printed PLA-10%HAp composite. (a) SEM image of transversely cut PLA-10%HApfilament
scanned at 20 kV. The filament’s polymermatrix’s distribution of (b) oxygen, (c) calciumand (d) phosphorouswere detected. (e) SEM
image of transversely cut 3D-printed PLA-10%HAp scanned at 20 kV. (f)Elemental spectral analysis of the PLA-10%HAp composite
production stages, from top to bottom at 1.5 keV, curves correspond to pre-extrusion composite, composite filament, pure PLA
filament, and 3D-printed composite. EDSwas performed on the highlighted area of the SEM image to analyze for elemental signals of
HAp. The 3D-printed polymermatrix’s distribution of (g) oxygen, (h) calcium and (i) phosphorouswere detected.
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attachment to the 10% HAp composite over the 20%
HAp version might arise from the former producing
more consistent surfaces during 3D-printing. This
would allow cells to also attach more consistently and
uniformly and would account for the wider standard
deviation seen for the 20%HAp.
As it is usually pointed out in the literature, normal
biological and physical degradation of PLA produces
no by-products other than lactic acid, which is readily
metabolized, and will only accumulate to cause
inflammatory responses over long periods of stagna-
tion [67, 68]. In vitro, the mechanisms to cope with
lactic acid leachate from the samples are likely to be
similar to in vivo vascular drainage, since culture med-
ium is regularly changed. Relevant to this in vitro set-
ting, osteosarcoma cells—such as the MG63 cell-line
—have been found to express MCT receptors, includ-
ing MCT-1, which facilitates lactic acid uptake [69]. It
is therefore likely that cells in the tissue culture wells
dispose of excess lactic acid through their own meta-
bolism, while the as-per-protocol culture medium
changes and well washes during the study do not allow
for an unmanageable build-up of the by-product.
The creation of a composite with PLA and HAp as
a means to promote bone regeneration has been based
on the fact that HAp has been documented to enhance
repair in bone lesions by favouring overall osteointe-
gration of implants [14, 42, 70–73]. Coupled with the
biocompatibility and bioresorbability of PLA, such a
material could yield numerous benefits in complex
skeletal-repair situations, such as reconstruction of
facial structures in growing children—in whom it is
desirable for implant materials to resorb quickly to
prevent craniofacial malformation. In this study we
have documented a general production method for a
3D-printing composite filament. Previous research in
similar compositing for electro-spinning suggested
that—in terms of in vitro cell response—the ideal
amount of HAp in a polymer mix was somewhere
below 10% as an additive for electrospinning (another
additive manufacturing technique) [74], while other
studies in FFF have found printable blends of up to
50% HAp with favourable cell response [6, 7, 9]. In
this study, the results for 20% HAp concentrations
suggests that higher concentrations ofHAp have bene-
fits on the biological response. However, considering
Figure 8.μCT images of 3D-printed discmadewith PLA-10%HAp composite. (a)Uppermost axial projection image of a 1 cmdisc
sample; (b) photograph of 3D-printed sample disc shown in relationship to a 3D-printed tensile bar specimen; (c) 3D reconstruction
of the sample’s volume using 2 μmslice thickness; (d) 3D reconstruction of the sample’s volumewith reconstruction parameters
adjusted to filter out themore radiolucentmaterial: the remaining particles shown are assumed to correspond toHAp.
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that all measurements except collagen deposition were
similar for all concentrations of HAp, these benefits
may not improve significantly with further increasing
the HAp content of the material. In the case of
10%HAp,
Moreover, increasing HAp concentration rapidly
becomes problematic for material processing and
printing. Extruding and 3D-printing the 20% HAp
composite proved to be more challenging that for the
10% HAp under the conditions described here. Dur-
ing extrusion into filament, uniform flow of the sof-
tened polymer was prohibitively difficult to achieve.
This resulted in persistent and unavoidable imperfec-
tions on the surface of the resulting filament, along
with naked-eye-noticeable inconsistencies in its dia-
meter. These irregularities make it hard for the 3D-
printer to produce optimal-quality prints, and even-
tually result in either fracture of the filament, or clog-
ging of the printer’s extruding mechanisms within
minutes—seemingly via accumulation of HAp in the
channel leading from the heating chamber to the noz-
zle. The 5% and 10% HAp composites showed no
such problems with filament extrusion, though prin-
ter blockage did occur after several hours of use of
thesefilaments.
The higher concentration of HAp in the 20%HAp
composite probably allows for the powder to agglom-
erate during themelting phase of the compositing pro-
cess. These HAp agglomerates could then consolidate
further under the pressure of the driving screw during
extrusion, which is likely to produce the 250MPa
required for cold isostatic pressing of HAp [75]. Given
the larger agglomerates of ceramic observed in
figure 8(d), we theorize that improving the uniformity
of the HAp powder dispersion on the polymer before
melting could potentially resolve this issue (by pre-
venting these agglomerates from forming), but that
would require grinding the PLA pellets further, or the
use of a solvent to thoroughly homogenize the mix-
ture. The Filabot extruder requires the pellets be large
enough for the driving screw to force them in to the
melting chamber; as such, there is a limit to the pellet
size suitable to use for this device (which is likely
around 3 mm, as the device was designed to accept
commercial plastic pellets); commercial-size granules
would likely not be extrudable with this device. Alter-
natively, using a solvent poses several biological safety
issues, mainly the difficulty of assuring it has been
completely evaporated during extrusion and printing,
especially since the composite is meant for resorbable
implants—the productionmethod here presentedwas
designed purposefully to avoid the use of solvents.
Moreover, the amount of solvent required to process
hundreds to thousands of grams of PLA would be
costly and problematic with regards to disposal.
For the former reasons, under the conditions of
this study, the 20% HAp composite was deemed
unsuitable to use, despite it showing a tendency to
encourage the deposition of collagen on the MG63
cell-line. The remaining two composite concentra-
tions showed no further differences, except for the sig-
nificantly better in vitro cell attachment properties of
the 10%HAp composite. Overall, ease of manufactur-
ing was the main reason this version of the composite
was favoured for the remainder of this study. We do
not completely discard the possibility that further
in vitro testing may provide evidence in favour of
higher concentrations, which would require refine-
ment of our productionmethods.
Figure 9.Differential calorimetry curves for the studied PLA-HAp composite through its production stages. The usual crystallization
peaks for PLA can be observed at around 90 ºC,withmelting peaks near 180 ºC. From top to bottom curves, averagemelting peaks for
eachmaterial (n=3)were observed at 174.8 ºC, 176.0 ºC, 176.8 ºC, and 175.8 ºC. Endothermic processes are arbitrarily depicted
downwards.
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The addition of this relatively small amount of
HAp to the PLA polymer matrix was not expected to
impact on the overall mechanical properties of the
printed parts. Other studies on PLA-ceramic compo-
sites for FFF have found an increase in mechanical
properties with no change on the in vitro degradation
profile of the material in simulated bodily fluids at
37 ° C [14]. This is not surprising, since in vitro degra-
dation of PLA at physiological temperatures has con-
sistently been found to happen over months to years
[76–78]. It is worth mentioning that the mechanical
properties for this material are low compared to usual
values for PLA manufactured through other processes
[38, 79–81], but our proposed application in facial
reconstruction is aimed at non-load bearing sections
of the skull, and thusmechanical properties a not con-
sidered critical. The filament production processes, on
the other hand, were a concern in this respect, as they
involve several cycles of melting and cooling. The sig-
nificant drop in tensile strength and elastic modulus
found in 3D-printed samples with the 10% HAp com-
posite could be explained as being a reflection of
increased crystallinity, but no significant difference was
found compared to the reference 3D-printed PLA.
Annealed PLA tensile bars produced through 3D-print-
ing showed a similarly lowering tensile strength, along
with an increase in crystallinity, with elasticity remain-
ing similar to the reference material. This suggests that
increased crystallinity may not be the main factor
affectingmechanical resistance on this composite.
Other research has found that PLA-HAp compo-
sites (produced through hot pressing) achieve higher
tensile strengths and elastic moduli, probably due to
the superposition of themechanical properties of both
materials [45]; those composites were prepared
through mixing in solvent, and with a much higher
HAp concentration (70% to 85% by weight). The
samemechanisms might not apply to the present pro-
duction methods—even though thorough dispersion
of HAp is achieved—due to the concentrations
allowed by this study’s methods being much lower.
The layer-layer interface in 3D-printed parts is also
proposed to counter whatever benefits HAp compo-
siting brings to the material, since they 3D-printing
results in lower tensile strengths than those found
moulded or pressed PLA [76, 79, 82, 83].
Further insight on this phenomenon could arise
from analyzing the molecular weight of the polymer
during processing, as repeated melting under a non-
dry atmosphere could potentially degrade it, explain-
ing the compromise on its mechanical properties
[76, 78, 84–87]. The lower concentration of HAp
could also mean that the ceramic particles are simply
embedded within the polymer matrix, interrupting
intermolecular interactions between PLA chains, and
thus accounting for part of the lowering of mechanical
properties.
Likewise, the lowering of melting peak observed
for the composite after 3D-printing is likely reflective
of lowering of the molecular weight of the polymer
matrix due to repeated thermal treatments during
processing—this would, in turn, weaken the mechan-
ical resistance of the final samples. The resulting
upward shift in the calorimetry curves could be the
result of intermolecular interactions with hydroxyl
moieties provided by the presence of HAp [88], which
could potentially facilitate hydrogen bonding to
account for the heightened heat capacity at the com-
positing stages before 3D-printing. Furthermore, the
self-reinforcing phenomenon [89] could also be a
potential explanation for the second shift happening
after 3D-printing, since polymer-chain alignment
could further favour intermolecular interactions with
HAp particles, and likely strengthen them through
reorientation into more favourable bonding angles on
amore tightly packedmatrix.
5. Conclusions
We present here a method for producing a PLA-HAp
composite 3D-printing filament for the production of
implantable, resorbable devices for bone regeneration
in the context of maxillofacial reconstruction. PLA is
used as an inert structural material to which HAp
particles are added solvent-free as a functionalizing
agent to promote osteoconduction and osteoinduc-
tion. This composite filament allows for free-form-
fabrication in commercial-grade 3D-pritners, and has
the potential to be used in the treatment of complex
bone defects and lesions where standardized plates,
screws, and autologous implants are geometrically or
mechanically sub-optimal. Our evidence suggests that
the process is biologically safe, and—in the mid-term
—would require minor adjustments (such as steriliz-
ing the filament extruder and 3D-printer) to move
forward to in vivo testing for biocompatibility, bone-
regeneration capabilities, and implant degradation.
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